Company: BDRX
Filing Date: 2025-01-08
Form Type: 424B3
Source: 0001214659-25-000303
Chunk: 96

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-08
Form: 424B3
Chunk 96
---
Issuance Date: December 23, 2024

Number: BDRX-1

FOR VALUE RECEIVED, Biodexa
Pharmaceuticals PLC, a public limited company organized under the laws of England and Wales (the “”), hereby
promises to pay C/M Capital Master Fund, LP, a Delaware limited partnership, or its registered assigns (the “”),
the amount set out above as the Original Principal Amount (as reduced pursuant to the terms hereof pursuant to repayment, redemption or
otherwise, the “”), in each case when due, and to pay interest (“”) on any outstanding
Principal at the applicable Interest Rate (as defined below) from the date set out above as the Issuance Date (the “”) until the same becomes due and payable, whether upon the Maturity Date or acceleration, redemption or otherwise (in each
case in accordance with the terms hereof). Certain capitalized terms used herein are defined in Section (10). The Issuance Date is the
date of the first issuance of this Promissory Note (the “”) regardless of the number of transfers and regardless
of the number of instruments, which may be issued to evidence such Note. This Note was issued with a 10% original issue discount.

(1)

(a) .
On the Maturity Date, the Company shall pay to the Holder an amount in cash representing all outstanding Principal, accrued and unpaid
Interest, and any other amounts outstanding pursuant to the terms of this Note. The “” shall be the one
(1) year anniversary of the Issuance Date, as may be extended with the prior written consent of the Holder.

(b) . Interest shall accrue on the outstanding Principal balance hereof at an annual rate equal to 5% (“”),
which Interest Rate shall increase to an annual rate of 18% upon an Event of Default for so long as it remains uncured. Interest shall
be calculated based on a 365-day year and the actual number of days elapsed, to the extent permitted by applicable law.

(c) .
On or before each date (each, an “”) set forth on the repayment schedule attached hereto as (the “”), the Company shall repay a portion of the outstanding balance of this Note in cash,
in an amount equal to the Principal amount set forth on the Repayment Schedule as of such Installment Date, minus any amount pre-paid
prior to the Installment Date, plus all accrued and unpaid Interest on this Note as of such